Should kids be tested for lipid disorders?

Article

After studying the issue, the US Preventive Services Task Fore (USPSTF) cannot recommend for or against the routine screening for dyslipidemia in children, adolescents, and young adults (up to 20 years of age).[more]

Recent Videos
Russell Libby, MD, FAAP
Greg Forlenza, MD
Lawrence Eichenfield, MD
Nathan Kuppermann, MD, MPH
COVID-19 Roundtable: Considering off label therapies
Greg Forlenza, MD
Greg Forlenza, MD
COVID-19 Therapy Roundtable: Focusing on Inpatient Care | Image credit: Production Perig
Image credit: Production Perig
Related Content
Weekly review: New peanut patch data, norovirus outbreaks, and more

Weekly review: New peanut patch data, norovirus outbreaks, and more

Joshua Fitch, Senior Editor
January 13th 2025
Article

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.

Site Logo

Food Insecurity and the Dangers of Infant Formula Dilution

January 30th 2023
Podcast
Data: 80% of INZ-701-treated infants with ENPP1 Deficiency survived past first year | Image Credit: © Bostan Natalia - © Bostan Natalia - stock.adobe.com.

Data: 80% of INZ-701-treated infants with ENPP1 Deficiency survived past first year

Joshua Fitch, Senior Editor
January 10th 2025
Article

Positive interim data was reported from the ENERGY 1 trial and Expanded Access Program that featured a total of 5 infants and 1 child.

Demystifying Infant Formula

Demystifying Infant Formula

October 11th 2022
Podcast
CDC: 2024-2025 seasonal norovirus outbreaks up from previous years | Image Credit: © Vitalii Vodolazskyi - © Vitalii Vodolazskyi - stock.adobe.com.

CDC: 2024-2025 seasonal norovirus outbreaks up from previous years

Joshua Fitch, Senior Editor
January 9th 2025
Article

Based on reports by NoroSTAT-participating states, the total number of outbreaks in 2024-2025 seasonal year is above the range reported 012–2020 and 2021-2024 seasonal years.

Study: Nearly 80% of infants born in 2023-24 RSV season received RSV protection | Image Credit: © Peter Hansen - © Peter Hansen - stock.adobe.com.

Study: Nearly 80% of infants born in 2023-24 RSV season received RSV protection

Joshua Fitch, Senior Editor
January 8th 2025
Article

The study within a single health care system revealed that most infants born prior to December received the nirsevimab monoclonal antibody.

© 2025 MJH Life Sciences

All rights reserved.